These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1208597)

  • 1. Prevention of hypertension in the SH rat: effects of differential central catecholamine depletion.
    Erinoff L; Heller A; Oparil S
    Proc Soc Exp Biol Med; 1975 Dec; 150(3):748-54. PubMed ID: 1208597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional brain catecholamine levels and the development of hypertension in the spontaneously hypertensive rat: the effect of 6-hydroxydopamine.
    van den Buuse M; de Kloet ER; Versteeg DH; de Jong W
    Brain Res; 1984 Jun; 301(2):221-9. PubMed ID: 6428702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central depletion of catecholamines--importance of hypertension and anesthesia.
    Woodside JR; Beckman JJ; Althaus JS; Miller ED
    Anesth Analg; 1984 May; 63(5):482-8. PubMed ID: 6424508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of dopamine in the development of spontaneous hypertension.
    van den Buuse M; Versteeg DH; de Jong W
    Hypertension; 1984; 6(6 Pt 1):899-905. PubMed ID: 6519747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of forebrain noradrenaline innervation to the central circulatory effects of alpha-methyldopa and 6-hydroxydopamine.
    van den Buuse M; Head GA; Korner PI
    Brain Res; 1991 Feb; 541(2):300-8. PubMed ID: 1905177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurogenic hypertension after depletion of norepinephrine in anterior hypothalamus induced by 6-hydroxydopamine administration into the ventral pons: role of serotonin.
    Benarroch EE; Balda MS; Finkielman S; Nahmod VE
    Neuropharmacology; 1983 Jan; 22(1):29-34. PubMed ID: 6405300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of intraventricular and intraspinal 6-hydroxydopamine on blood pressure of apontaneously hypertensive rats.
    Kubo T; Hashimoto M
    Arch Int Pharmacodyn Ther; 1978 Mar; 232(1):166-76. PubMed ID: 666457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain noradrenaline and the development of hypertension: the effect of treatment with central 6-hydroxydopamine or DSP-4.
    van den Buuse M; Versteeq DH; de Jong W
    Clin Exp Pharmacol Physiol; 1986 Jun; 13(6):469-76. PubMed ID: 3093124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional depletion of central nervous system catecholamines: effects on blood pressure and drinking behavior.
    Gordon FJ; Brody MJ; Johnson AK
    Brain Res; 1985 Oct; 345(2):285-97. PubMed ID: 3930004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failure to produce blood pressure changes following pharmacological or surgical depletion of brain serotonin in the spontaneously hypertensive rat.
    Browning RA; Bramlet DG; Myers JH; Bundman MC; Smith ML
    Clin Exp Hypertens (1978); 1981; 3(5):953-73. PubMed ID: 6456876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of depletion of spinal noradrenaline by 6-hydroxydopamine on the development of renal hypertension in rats.
    Bosland MC; Versteeg DH; van Put J; de Jong W
    Clin Exp Pharmacol Physiol; 1981 Jan; 8(1):67-77. PubMed ID: 7471522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental central hypertension produced by chemical degeneration of the locus coeruleus in the rat.
    Ogawa M; Fujita Y; Ozaki M
    Jpn Circ J; 1979 Feb; 43(2):89-98. PubMed ID: 36487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain dopamine depletion by lesions in the substantia nigra attenuates the development of hypertension in the spontaneously hypertensive rat.
    van den Buuse M; Versteeg DH; de Jong W
    Brain Res; 1986 Mar; 368(1):69-78. PubMed ID: 3006867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic administration of naltrexone alters central catecholamine levels but not the development of hypertension in spontaneously hypertensive rats.
    Strahlendorf JC; Strahlendorf HK; McKown-Pulliam R; Hughes MJ; Lang IM
    Neuropharmacology; 1982 Nov; 21(11):1195-8. PubMed ID: 7177344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central 6-OHDA affects both open-field exploratory behaviour and the development of hypertension in SHR.
    Van den Buuse M; Veldhuis HD; de Boer S; Versteeg DH; de Jong W
    Pharmacol Biochem Behav; 1986 Jan; 24(1):15-21. PubMed ID: 3080759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential blood pressure responses to intracisternal clonidine, alpha-methyldopa, and 6-hydroxydopamine in conscious normotensive and spontaneously hypertensive rats.
    Head GA; de Jong W
    J Cardiovasc Pharmacol; 1986; 8(4):735-42. PubMed ID: 2427812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction between noradrenergic and serotonergic mechanisms on the central regulation of blood pressure in the rat: a study using experimental central hypertension produced by chemical lesions of the locus coeruleus.
    Ogawa M
    Jpn Circ J; 1978 May; 42(5):581-97. PubMed ID: 151755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormalities in hypothalamic and neurohypophysial vasopressin content are not a consequence of hypertension in the spontaneously hypertensive rat.
    Sladek CD; Devine MA; Felten SY; Aravich PF; Blair ML
    Brain Res; 1988 Mar; 445(1):39-46. PubMed ID: 3130152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central catecholamine depletion, vasopressin, and blood pressure in the DOCA/NaCl rat.
    Okuno T; Winternitz SR; Lindheimer MD; Oparil S
    Am J Physiol; 1983 Jun; 244(6):H807-13. PubMed ID: 6407335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of 6-hydroxydopamine on hypertension and noradrenaline content in the brain and heart of spontaneously hypertensive rats].
    Nikodijević O
    Acta Med Iugosl; 1975; 29(3):231-41. PubMed ID: 1146602
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.